TRANSCRIPT

Q3 2021 — Earnings call remarks

Q3 2021PDF · 8 pages152 KB
1
Earnings Conference Call
Third Quarter 2021 Remarks
October 14, 2021
Moderator:
Good morning, and welcome to the UnitedHealth Group Third Quarter 2021 Earnings
Conference Call. A question and answer session will follow UnitedHealth Group’s prepared
remarks. As a reminder, this call is being recorded.
Here is some important introductory information. This call contains “forward-looking” statements
under U.S. federal securities laws. These statements are subject to risks and uncertainties that
could cause actual results to differ materially from historical experience or present expectations.
A description of some of the risks and uncertainties can be found in the reports that we file with
the Securities and Exchange Commission, including the cautionary statements included in our
current and periodic filings.
This call will also reference non-GAAP amounts. A reconciliation of the non-GAAP to GAAP
amounts is available on the “Financial & Earnings Reports” section of the Company’s Investor
Relations page at www.unitedhealthgroup.com.
Information presented on this call is contained in the Earnings Release we issued this morning
and in our Form 8-K dated October 14, 2021, which may be accessed from the Investor
Relations page of the Company’s website. I will now turn the conference over to the president
and chief operating officer of UnitedHealth Group, Dirk McMahon.
Dirk McMahon:
Good morning and thank you for joining us today. Unfortunately, our CEO and
colleague, Andrew, is not with us this morning since he had an urgent but
straightforward procedure last night for a kidney stone. All went very well, and we
expect him fully back in just a few days. I’m quite confident he is listening now … so I
hope you’re doing well, boss. John Rex and I will be subbing for Andrew this morning
and we have our management team with us as usual to help with your questions.
We’re here today to discuss third quarter results and the expanding opportunities we
see looking ahead.

-- 1 of 8 --

2
As a result of the progress at both Optum and UnitedHealthcare, we have increased our
2021 adjusted earnings outlook to a range of $18.65 to $18.90 per share.
We continue to prioritize three themes Andrew has discussed before which are
foundational to the growth of our enterprise:
• First, unlocking the collaborative potential within Optum and UnitedHealthcare for
the benefit of all.
• Second, further developing our technology and data science platform to aid patient
care and experience and to help the system run better.
• Third, strengthening our consumer experience, capabilities and value.
I’ll briefly highlight a couple of items for you.
You likely have seen the CMS Medicare Advantage Star quality ratings showing 95% of
our UnitedHealthcare members will be in 4-star rated plans or better for 2023, up from
78% for 2022 and a new high for our company. Within Optum Care, on behalf of the
many payers we serve, 99% of Medicare Advantage patients will be in 4-star plans or
better for 2023.
A second important highlight in the quarter: We were encouraged by the ongoing
strength in our employer and individual business, which has now grown by over 330,000
people this year, with revenue up 7% year-over-year. We continue to see active interest
in our product innovations, such as our All Savers level-funded offering, and are
encouraged by our competitiveness in the market and momentum heading into 2022.
We also elevated consumer connectivity by incorporating fitness offerings from industry-
leading partners.
OptumHealth continues to build momentum as well. Entering the open enrollment
period for Medicare Advantage, we have more than 2.2 million people served under

-- 2 of 8 --

3
physician-led, fully accountable care arrangements, and expect ’22 to be another year
of record expansion in this key part of our portfolio.
Our broad, home-based clinical care initiatives at Optum and UnitedHealthcare are
central to improving near- and longer-term health outcomes for people with medical,
behavioral and social needs. These efforts include Optum at Home, which delivers high-
quality primary care services in the convenience of the home setting and supports
recovery after hospitalizations. Seniors served by our home and community offering
experience a 14% lower rate of hospital admissions and about a 4% higher rate of
physician encounters.
In addition to caring for people in their homes, we continue to expand capabilities in
other optimal sites of care, including via digital means.
Optum is distinctively enabling virtual care for patients using their own primary care
physicians and with behavioral clinicians. For example, a physician engaging in a virtual
visit with a patient can easily bring in a behavioral health professional for a real-time
consultation. UnitedHealthcare is using Optum’s virtual capabilities to introduce a new
suite of digital-first products, offering a near seamless experience between virtual and
traditional primary, specialty and urgent care.
We expect during 2022 and beyond to further build on these opportunities to connect
and integrate multiple channels of care, simplify the experience for patients and
providers and deliver quality care that is affordable and in the optimal setting.
Let me now go a little deeper in a few areas to give you an assessment of how we are
doing on the themes I mentioned at the outset.
OptumInsight continues to drive better clinical and operational performance at the
health system level. Last week we reached a new multiyear partnership with the leading
and innovative health system, SSM Health … whose 40,000 employees, 33 hospitals

-- 3 of 8 --

4
and post-acute facilities, and 300 physician clinics serve the people of Missouri,
Oklahoma, Wisconsin and Illinois.
OptumInsight brings real value in helping health systems strengthen and scale essential
functions, such as care coordination, revenue cycle management and digital
modernization, all to improve health outcomes and patients’ care experiences. These
and similar efforts simplify processes, reduce administrative burdens and help our
partners focus more attention on their core missions of patient care.
OptumRx continues to deliver value to health system partners, such as its new
multiyear agreement with Point32Health, which serves more than 2 million people in
New England through its founding organizations, Harvard Pilgrim Health Care and Tufts
Health Plan. OptumRx will provide integrated pharmacy benefit and specialty offerings
that will enhance services and deliver improved affordability for their plan members.
OptumRx is having a substantial impact through its community behavioral health
pharmacies, which now serve nearly 700,000 people with mental health, addiction and
other conditions through more than 600 dispensaries across 47 states. The pharmacies
deliver a high-touch approach to care that contributes to a more than 90% medication
adherence rate and lowers emergency room visits and hospitalizations by 18% and
40% respectively, driving better health outcomes and lower total cost of care.
Within our UnitedHealthcare government businesses, we have increased processing
efficiency by 25% over the last year by using Optum technology to improve auto-
adjudication rates and intelligent work distribution to appropriately skilled channels. We
have many such initiatives underway across the enterprise in affordability, provider
experience and product development as we employ advanced technology and data
analytics to drive even greater value for the people we serve and the health system.
Before turning over the call to John, a quick word on our pending combination with
Change Healthcare. We continue to work diligently to satisfy regulatory requests and

-- 4 of 8 --

5
now believe, based on our experience so far, the transaction should close in the first
part of 2022.
We are highly energized about the positive impact we can have working together with
the exceptional Change team; a team aligned with our mission and values and focused
on delivering substantial benefits for the health care system. These benefits will include:
• Helping clinicians by simplifying access to real-time evidence-based guidance as
they are serving patients.
• Closing gaps in care more rapidly to improve health outcomes and lower costs.
• Reducing unnecessary complexity by removing administrative waste and
obstruction to make the care process simpler, more cost-effective and more
transparent.
• And bringing greater convenience and simplicity to managing consumer health
finances while ensuring care providers get paid more quickly and accurately.
Optum and Change Healthcare’s capabilities fundamentally are complementary and
distinct. Because both companies already successfully serve health plans and state
governments, care providers and consumers in a highly competitive market, we believe
this combination will make the health care system work better for everyone, and bring
exceptional value to those we serve.
With that, I’ll turn it over to our Chief Financial Officer John Rex.
John Rex:
Thank you, Dirk.
This morning we reported third quarter and year-to-date revenues of
$72 and $214 billion respectively, growth of 11 and 12% over last year.
This growth was led by OptumHealth – primarily our care businesses.

-- 5 of 8 --

6
In the third quarter, the Optum platform comprised 54% of enterprise operating earnings
and continues to show strong growth momentum.
Our performance reflects the diverse and complementary strengths of our business,
setting the stage for growth in the years ahead. Our updated full year 2021 outlook
includes unfavorable COVID impacts consistent with the expectations we have
discussed throughout the year.
During the third quarter, while direct COVID care and testing costs ran above the
expectations we had nearly a year ago, we again saw elective care offsetting the
impacts of higher case rates, much like previous cycles in the pandemic.
This quarter there were approximately 60,000 COVID hospitalizations — meaningfully
above the second quarter — with the month of August peaking at nearly 30,000 and
then declining in September.
Looking at specific business performance: OptumHealth’s third quarter revenue and
earnings increased 32% and 37% respectively year-over-year. Revenue per consumer
grew by 30%. This reflects the increasing impact and number of value-based
relationships within Optum Care, the expansion of our in-home and community health
platform, as well as the growing acuity of the needs we can serve.
OptumInsight’s revenue grew 13% in the quarter and earnings grew 15%, as the
revenue backlog increased by 12% to $22.3 billion. We see overall business
development sourcing and activity levels increasing, particularly with care provider
customers and for our software and analytics offerings.
OptumRx revenue and scripts grew 6% year-over-year and earnings 5%. OptumRx is
seeing both strong customer retention levels and sales success for the largely
completed ’22 selling season and early activity for ’23.

-- 6 of 8 --

7
Turning to UnitedHealthcare, the third quarter showed increasing member growth in our
commercial offerings, particularly in employer-sponsored benefits. Increased
employment is a broad underlying contributor, but we are particularly encouraged by the
growth we are achieving in our affordable, consumer-centric offerings.
Medicare Advantage membership has grown 745,000 this year. Inclusive of plans which
serve dual special needs members, we expect to add a total of over 900,000 Medicare
Advantage members.
The number of people served through managed Medicaid grew by more than 1 million
members over last year as we began to serve people in new regions such as North
Carolina, Kentucky and Indiana, and as state-based redetermination activities remained
paused. We were honored to begin serving people in the Missouri Medicaid expansion
this month.
Our liquidity and capital positions remain strong, with third quarter cash flows from
operations at $7.6 billion, or 1.8 times net income, and we ended the quarter with a
debt-to-capital ratio of 39%.
As noted earlier, given the strength of our business performance, this morning we
updated our 2021 adjusted earnings outlook to a range of $18.65 to $18.90 per share.
Now, with the close of the third quarter, your attention understandably turns to next
year. As is our custom, we will offer a few early observations here, while reserving the
majority of this conversation for our November 30 Investor Conference, which we hope
will be held in person in New York.
Our businesses are both growing and operating well, with strong momentum heading
into next year.

-- 7 of 8 --

8
While the pandemic-related impacts remain difficult to predict, given the current trends,
we would expect a lower unfavorable COVID impact than experienced in 2021. Still, as
the dramatic variation of the last 20 months has demonstrated to all, prudent
management suggests we should offer an outlook respectful of the fact that the current
situation is without precedent.
Taking all elements together, at this distance, we see current analyst consensus as
reasonably beginning to calibrate a 2022 outlook, envisioning that consensus as being
toward the upper end of our initial adjusted earnings per share outlook range, with the
range being similar to that offered initially for 2021.
The still-untapped collaborative potential between UnitedHealthcare and Optum to
benefit individuals and the system; the power of applied technology to advance care
and service; improved opportunities in consumer health and experience; and the
passion of our people … these and so many other elements lead us to believe our
performance expectations for the years ahead remain fully supportive of our long-term
13 to 16% earnings per share growth outlook. We look forward to going into more detail
on both our view of 2022 and the many years of growth beyond, at our Investor
Conference.

-- 8 of 8 --